Abbott Laboratories (ABT) vs Gilead Sciences, Inc. (GILD)
A side-by-side comparison of Abbott Laboratories and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$101.96HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT
GILD
Gilead Sciences, Inc.
$143.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABT vs GILD
growth of $100 · dividends reinvested · last 10yABT +199.3% (+11.6%/yr)GILD +161.3% (+10.1%/yr)ABT compounded faster over this window
ABT GILD
ABT vs GILD: by the numbers
- •GILD is the larger company ($178.44B vs $176.43B market cap).
- •ABT is profitable (11.65% net margin) while GILD runs a net loss (-10.64%).
- •ABT grew revenue faster over the past five years (2.98% vs 2.72% CAGR).
- •ABT pays the higher dividend yield (2.40% vs 2.22%).
Metrics side by side
Valuation
| Metric | ABT | GILD |
|---|---|---|
| P/E ratio | 32.78 | N/A |
| Forward P/E | 18.48 | N/A |
| P/S ratio | 3.79 | 5.86 |
| P/B ratio | 3.45 | 15.09 |
| EV / EBITDA | 18.73 | N/A |
| FCF yield | 4.49% | 7.27% |
Profitability
| Metric | ABT | GILD |
|---|---|---|
| Gross margin | 56.80% | 79.59% |
| Operating margin | 17.03% | 39.74% |
| Net margin | 11.65% | -10.64% |
| ROE | 10.61% | -27.39% |
| ROIC | 6.07% | -3.66% |
Dividends
| Metric | ABT | GILD |
|---|---|---|
| Dividend yield | 2.40% | 2.22% |
| Payout ratio | 79.74% | N/A |
Growth (annualized)
| Metric | ABT | GILD |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 2.72% |
| EPS CAGR (5Y) | 8.22% | 133.83% |
| FCF CAGR (5Y) | 0.18% | 9.27% |
| Total return CAGR (5Y) | -2.42% | 19.60% |
Frequently asked
- Which has grown faster, ABT or GILD?
- Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus GILD at 2.72%.
- Does ABT or GILD pay a bigger dividend?
- ABT yields 2.40% and GILD yields 2.22% based on trailing dividends and the latest price.
- Is ABT or GILD more profitable?
- ABT runs the higher net margin — ABT at 11.65% versus GILD at -10.64%.
- How have ABT and GILD total returns compared?
- Over the past 10 years, ABT delivered 11.77% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioAbbott Laboratories dividend yieldGilead Sciences dividend yieldAbbott Laboratories ROEGilead Sciences ROEAbbott Laboratories operating marginGilead Sciences operating marginAbbott Laboratories revenue growthGilead Sciences revenue growthAbbott Laboratories free cash flowGilead Sciences free cash flow
Abbott Laboratories & Gilead Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.